1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > T-Cell Leukemia Global Clinical Trials Review, H1, 2014

T-Cell Leukemia Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H1, 2014" provides data on the T-Cell Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on T-Cell Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating T-Cell Leukemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

T-Cell Leukemia Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
T-Cell Leukemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of T-Cell Leukemia to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of T-Cell Leukemia to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of T-Cell Leukemia 24
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in T-Cell Leukemia Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on T-Cell Leukemia 33
Aug 23, 2012: Kyowa Hakko Kirin Initiates Pivotal Phase II Trial Of Mogamulizumab In Patients With Adult T-Cell Leukemia-Lymphoma In US And Europe 33
Apr 09, 2012: Study Demonstrates Potential Of New Anti-Leukemia Compound, Lenaldekar 33
Jan 25, 2012: Study Shows Leukemia Drug Kills Cancerous T-cells While Sparing Normal Immunity 34
Dec 07, 2010: Kyowa Hakko Kirin Announces Results From Japan Phase II Clinical Trial Of KW-0761 In Adult T-Cell Leukemia-Lymphoma 34
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Kirin Holdings Company, Limited 36
Clinical Trial Overview of Kirin Holdings Company, Limited 36
BioCryst Pharmaceuticals, Inc. 37
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 37
Celgene Corporation 38
Clinical Trial Overview of Celgene Corporation 38
Otsuka Holdings Co., Ltd. 39
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Mundipharma International Limited 41
Clinical Trial Overview of Mundipharma International Limited 41
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Angimmune LLC 43
Clinical Trial Overview of Angimmune LLC 43
Clinical Trial Overview of Top Institutes / Government 44
National Cancer Institute 44
Clinical Trial Overview of National Cancer Institute 44
Fred Hutchinson Cancer Research Center 47
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 47
Ministry of Health, Labour and Welfare, Japan 49
Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan 49
University of Washington 50
Clinical Trial Overview of University of Washington 50
Japan Clinical Oncology Group 51
Clinical Trial Overview of Japan Clinical Oncology Group 51
Memorial Sloan Kettering Cancer Center 52
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 52
National Heart, Lung, and Blood Institute 53
Clinical Trial Overview of National Heart, Lung, and Blood Institute 53
The University of Texas M. D. Anderson Cancer Center 54
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 54
Washington University School of Medicine 55
Clinical Trial Overview of Washington University School of Medicine 55
Thomas Jefferson University 56
Clinical Trial Overview of Thomas Jefferson University 56
Five Key Clinical Profiles 57
Appendix 122
Abbreviations 122
Definitions 122
Research Methodology 123
Secondary Research 123
About GlobalData 124
Contact Us 124
Disclaimer 124
Source 125

List of Tables
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Region, 2014* 7
T-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
T-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
T-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
T-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
T-Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
T-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of T-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2014* 15
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of T-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2014* 18
T-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase, 2014* 20
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
T-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
T-Cell Leukemia Therapeutics, Global, Suspended Clinical Trials, 2014* 24
T-Cell Leukemia Therapeutics, Global, Terminated Clinical Trials, 2014* 25
T-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
T-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
T-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
T-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2014* 36
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2014* 37
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 38
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 39
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 40
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma International Limited, 2014* 41
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 42
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Angimmune LLC, 2014* 43
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 44
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 47
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2014* 49
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 50
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Clinical Oncology Group, 2014* 51
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 52
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 53
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 54
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 55
T-Cell Leukemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014* 56

List of Figures
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
T-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
T-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
T-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
T-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
T-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of T-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2014* 15
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of T-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2014* 18
T-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
T-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
T-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
T-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
T-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
T-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 123

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023

Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market  Forecast-2023

Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Acute Myeloid Leukemia (AML) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Chronic lymphocytic leukemia- Market Insights, Epidemiology and Market Forecast-2023

Chronic lymphocytic leukemia- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Chronic lymphocytic leukemia - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Therapy Market in the UK

  • November 2016
    11 pages
  • Therapy  

  • United Kingdom  

View report >

Cancer Statistics in Russia

  • November 2016
    8 pages
  • Leukemia  

    Cancer  

    Radiography  

  • Russian Federat...  

View report >

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.